[
  {
    "reportName": "Condensed Balance Sheet",
    "data": {
      "header": "Condensed Balance Sheet - USD $ in Thousands",
      "period": "Sep. 30, 2024",
      "data": {
        "Restricted cash and restricted cash equivalents": 27281,
        "Investment securities (includes available-for-sale securities of $1,478,066 and $595,187 at fair value with associated amortized cost of $1,468,146 and $596,757, as of September 30, 2024 and December 31, 2023, respectively)": 1554285,
        "Loans held for sale, at fair value": 229072,
        "Loans held for investment, at fair value": 85445,
        "Loans held for investment, at amortized cost (less allowance for credit losses of $48,419 and $54,695, as of September 30, 2024 and December 31, 2023, respectively)": 1417262,
        "Servicing rights": 296127,
        "Property, equipment and software": 266226,
        "Goodwill": 1393505,
        "Intangible assets": 314959,
        "Operating lease right-of-use assets": 84149,
        "Other assets (less allowance for credit losses of $2,651 and $1,837, as of September 30, 2024 and December 31, 2023, respectively)": 882723,
        "Total assets": 341798,
        "Interest-bearing deposits": 24351778,
        "Noninterest-bearing deposits": 56008,
        "Total deposits": 24407786,
        "Accounts payable, accruals and other liabilities": 158,
        "Operating lease liabilities": 101028,
        "Debt": 94163,
        "Residual interests classified as debt": 658,
        "Total liabilities": 28258695,
        "Redeemable preferred stock, $0.00 par value: 100,000,000 and 100,000,000 shares authorized; â€” and 3,234,000 shares outstanding, as of September 30, 2024 and December 31, 2023, respectively": 0,
        "Common stock": 108,
        "Additional paid-in capital": 7751335,
        "Accumulated other comprehensive income (loss)": 8109,
        "Total permanent equity": 6121481,
        "Total liabilities, temporary equity and permanent equity": 34380176
      }
    },
    "periodOfReport": "2024-09-30",
    "dateFiled": "2024-11-07",
    "formType": "10-Q",
    "quarter": "Q3"
  },
  {
    "reportName": "Condensed Statement of Operations and Comprehensive Income",
    "data": {
      "header": "Condensed Statement of Operations and Comprehensive Income - USD $ in Thousands",
      "period": "3 Months Ended",
      "data": {
        "Other": 39562,
        "Total interest income": 723374,
        "Securitizations and warehouses": 31093,
        "Deposits": 248292,
        "Corporate borrowings": 12871,
        "Total interest expense": 292364,
        "Net interest income": 431010,
        "Loan origination, sales, and securitizations": 70085,
        "Servicing": 9927,
        "Technology products and solutions": 90896,
        "Loan platform fees": 55641,
        "Total noninterest income": 266111,
        "Total net revenue": 697121,
        "Technology and product development": 139714,
        "Sales and marketing": 214904,
        "Cost of operations": 123714,
        "General and administrative": 148921,
        "Goodwill impairment": 0,
        "Provision for credit losses": 6013,
        "Total noninterest expense": 633266,
        "Income (loss) before income taxes": 63855,
        "Income tax (expense) benefit": 244,
        "Net income (loss)": 60745,
        "Unrealized gains on available-for-sale securities, net": 9029,
        "Foreign currency translation adjustments, net": 563,
        "Total other comprehensive income": 9592,
        "Weighted average common stock outstanding - basic (in shares)": 1071159746,
        "Weighted average common stock outstanding - diluted (in shares)": 1104450416
      }
    },
    "periodOfReport": "2024-09-30",
    "dateFiled": "2024-11-07",
    "formType": "10-Q",
    "quarter": "Q3"
  },
  {
    "reportName": "Condensed Statement of Cash Flow",
    "data": {
      "header": "Condensed Statement of Cash Flow - USD $ in Thousands",
      "period": "9 Months Ended",
      "data": {
        "Share-based compensation expense": 179785,
        "Depreciation and amortization": 149953,
        "Goodwill impairment": 0,
        "Deferred debt issuance and discount expense": 10821,
        "Gain on extinguishment of convertible debt": 0,
        "Provision for credit losses": 24835,
        "Fair value changes in loans held for investment": 0,
        "Fair value changes in securitization investments": 1067,
        "Changes in loans previously classified as held for sale, net": 994041,
        "Servicing assets": 6210,
        "Other assets": 15052,
        "Accounts payable, accruals and other liabilities": 29594,
        "Proceeds from sales of available-for-sale investments": 164623,
        "Proceeds from maturities and paydowns of available-for-sale investments": 616451,
        "Proceeds from sales of loans held for investment": 434483,
        "Proceeds from securitization investments": 69455,
        "Proceeds from non-securitization investments": 3579,
        "Acquisition of businesses, net of cash acquired": 0,
        "Net change in deposits": 5654019,
        "Net change in debt facilities": 902777,
        "Proceeds from other debt issuances": 845250,
        "Purchase of capped calls": 0,
        "Unwind of capped calls": 10180,
        "Proceeds from stock option exercises": 770,
        "Redemption of Series 1 preferred stock": 0,
        "Net cash provided by financing activities": 3813743,
        "Effect of exchange rates on cash and cash equivalents": 248,
        "Net (decrease) increase in cash, cash equivalents, restricted cash and restricted cash equivalents": 1450715,
        "Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period": 3615578,
        "Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period": 2969759,
        "Cash and cash equivalents": 2354965,
        "Restricted cash and restricted cash equivalents": 614794,
        "Total cash, cash equivalents, restricted cash and restricted cash equivalents": 2969759,
        "Extinguishment of convertible notes by issuance of common stock": 677147,
        "Deposits credited but not yet received in cash": 133104,
        "Deconsolidation of securitization and residual debt": 0,
        "Share-based compensation capitalized related to internally-developed software": 29297,
        "Available-for-sale securities sold but unpaid": 21266
      }
    },
    "periodOfReport": "2024-09-30",
    "dateFiled": "2024-11-07",
    "formType": "10-Q",
    "quarter": "Q3"
  }
]